Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor vs Ticagrelor in STEMI patients undergoing PPCI
NCT02733341Phase 4Completed
- Sponsor
- The Royal Wolverhampton NHS Trust
- Start
- Jul 2016
- Primary completion
- Oct 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor in ST-segment elevation myocardial infarction (STEMI), sponsored by The Royal Wolverhampton NHS Trust. Started Jul 2016; status: completed.
02
Drugs
cangrelor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02733341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733341.